UA93479C2 - Allergen dosage form - Google Patents

Allergen dosage form

Info

Publication number
UA93479C2
UA93479C2 UAA200506275A UA2005006275A UA93479C2 UA 93479 C2 UA93479 C2 UA 93479C2 UA A200506275 A UAA200506275 A UA A200506275A UA 2005006275 A UA2005006275 A UA 2005006275A UA 93479 C2 UA93479 C2 UA 93479C2
Authority
UA
Ukraine
Prior art keywords
allergen
dosage forms
dosage form
fast
dispersing
Prior art date
Application number
UAA200506275A
Other languages
English (en)
Ukrainian (uk)
Inventor
Кристиан Гаугуин Хафтон
Аннетте Реммельмайер Лундегорд
Хенрик Хьюго Якоби
Стиг Осмуль-Ольсен
Лизе Лунд Меркедаль
Ян Сендергорд Андерсен
Original Assignee
Альк-Абелло A/C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Альк-Абелло A/C filed Critical Альк-Абелло A/C
Publication of UA93479C2 publication Critical patent/UA93479C2/ru

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W90/00—Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
    • Y02W90/10—Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

 Изобретение обеспечивает фармацевтические препараты, которые содержат аллергены, и, в частности, быстродиспергирующиеся твердые аллергенные лекарственные формы, пригодные для оромукозального применения. Пригодными основами являются желатин, крахмал и манитол. Также раскрыты способы приготовления таких лекарственных форм.
UAA200506275A 2002-11-26 2003-11-14 Allergen dosage form UA93479C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200201825 2002-11-26

Publications (1)

Publication Number Publication Date
UA93479C2 true UA93479C2 (en) 2011-02-25

Family

ID=35964203

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200506275A UA93479C2 (en) 2002-11-26 2003-11-14 Allergen dosage form

Country Status (4)

Country Link
CN (1) CN1731979B (ru)
EC (1) ECSP055895A (ru)
UA (1) UA93479C2 (ru)
ZA (1) ZA200505111B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2167084B1 (en) * 2007-06-12 2013-04-24 ALK-Abelló A/S An allergen dosage form comprising an antihistamine
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
CN103675271B (zh) * 2013-12-23 2016-01-06 北京新华联协和药业有限责任公司 过敏性疾病变应原胶体金诊断试纸条及其制备方法
CN114053402A (zh) * 2020-08-03 2022-02-18 格林生物医药科技(天津)有限公司 一种过敏原制剂
CN114588130B (zh) * 2020-11-20 2023-07-04 四川好医生攀西药业有限责任公司 一种含美洲大蠊活性成分的创可贴及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions

Also Published As

Publication number Publication date
CN1731979B (zh) 2010-05-12
ZA200505111B (en) 2006-12-27
ECSP055895A (es) 2006-09-18
CN1731979A (zh) 2006-02-08

Similar Documents

Publication Publication Date Title
MXPA05005528A (es) Producto farmaceutico de alergeno.
IL138990A0 (en) Matrices for drug delivery and methods for making and using the same
TWI347201B (en) Pharmaceutical products,uses thereof and methods for preparing the same
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
WO2000051593A3 (en) Oral drug delivery system
AU2003217820A1 (en) Periocular drug delivery for diabetic retinopathy
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
AU2003297199A8 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
BG108516A (en) Pharmaceutical formulation
WO2004075875A8 (en) Dosage form having a saccharide matrix
AU2003300469A1 (en) Methods for making pharmaceutical dosage forms containing active cushioning components
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
ZA200208761B (en) Pharmaceutical form of administration for peptides, methods for its production and use.
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
CA2354039A1 (en) Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
UA93479C2 (en) Allergen dosage form
PL375000A1 (en) Fluorosiloxane matrix controlled diffusion drug delivery system
AU2002353246A1 (en) Oral veterinary drug delivery system and/or feed additive delivery system, process for the preparation and use thereof
UA87152C2 (ru) Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения
AU2003226746A1 (en) Intravaginal matrix drug delivery devices
ZA200405372B (en) Sedative non-benzodiazepine formulations.
AU2003227051A1 (en) Pack for medicine in capsule, pill or similar form
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
MY135825A (en) Tablets comprising flavourings and/or aromatizing substances
PL371518A1 (en) Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations